Osthole inhibits inflammatory cytokine release through PPARα/γ-mediated mechanisms in LPS-stimulated 3T3-L1 adipocytes

References

• Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010;316:129–139
   PubMed Web of Science ®Google Scholar
• Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004;15:2792–2800
   PubMed Web of Science ®Google Scholar
• Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001;60:349–356
   PubMed Web of Science ®Google Scholar
• Trujillo ME, Sullivan S, Harten I, et al. Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro. J Clin Endocr Metab 2004;89:5577–5582
   PubMed Web of Science ®Google Scholar
• Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010;314:1–16
   PubMed Web of Science ®Google Scholar
• Page JM, Harrison SA. NASH and HCC. Clin Liver Dis 2009;13:631–647
   PubMedGoogle Scholar
• Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology 1998;114:842–845
   PubMed Web of Science ®Google Scholar
• Schoonjans K, Staels B, Auwerx J. The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1996;1302:93–109
   PubMed Web of Science ®Google Scholar
• Mansour M. The roles of peroxisome proliferator-activated receptors in the metabolic syndrome. Prog Mol Biol Transl Sci 2014;121:217–266
   PubMed Web of Science ®Google Scholar
• Soares FLP, Matoso RD, Teixeira LG, et al. Gluten-free diet reduces adiposity, inflammation and insulin resistance associated with the induction of PPAR-alpha and PPAR-gamma expression. J Nutr Biochem 2013;24:1105–1111
   PubMedGoogle Scholar
• Cuzzocrea S, Bruscoli S, Mazzon E, et al. Peroxisome peroliferator-activated receptor-α contributes to the anti-inflammatory activity of glucocorticoids. Mol Pharmacol 2008;73:323–337
   PubMed Web of Science ®Google Scholar
• Kapadia R, Yi JH, Vemuganti R. Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front Biosci 2008;13:1813–1826
   PubMed Web of Science ®Google Scholar
• Tanaka N, Aoyama T. PPAR and NASH. Nippon Rinsho 2006;64:1089–1094
   PubMedGoogle Scholar
• Stienstra R, Mandard S, Patsouris D, et al. Peroxisome peroliferator-activated receptor (alpha) protects against obesity-induced hepatic inflammation. Endocrinology 2007;148:2753–2763
   PubMed Web of Science ®Google Scholar
• Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998;391:82–86
   PubMed Web of Science ®Google Scholar
• Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Obesity, inflammation and insulin resistance: which role for adipokines? Therapie 2007;62:285–292
   PubMedGoogle Scholar
• Zhang QY, Qin LP, He WD, et al. Coumarins from Cnidium monnieri and their antiosteoporotic activity. Planta Med 2007;73:13–19
   PubMed Web of Science ®Google Scholar
• Liu JX, Zhang WP, Zhou L, et al. Anti-inflammatory effect and mechanism of osthole in rats. J Chin Med Mater 2005;28:1002–1006
   Google Scholar
• Zhou F, Zhong W, Xue J, et al. Reduction of rat cardiac hypertrophy by osthole is related to regulation of cardiac oxidative stress and lipid metabolism. Lipids 2012;47:987–994
   PubMed Web of Science ®Google Scholar
• Qi ZG, Xue J, Zhang Y, et al. Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats. Planta Med 2011;77:231–235
   PubMed Web of Science ®Google Scholar
• Zhang JJ, Xue J, Wang HB, et al. Osthole improves alcohol-induced fatty liver in mice by reduction of hepatic oxidative stress. Phytother Res 2011;25:638–643
   PubMed Web of Science ®Google Scholar
• Zhao X, Xue J, Wang XL, et al. Involvement of hepatic peroxisome proliferator-activated receptor α/γ in the therapeutic effect of osthole on high-fat and high-sucrose-induced steatohepatitis in rats. Int Immunopharmacol 2014;22:176–181
   PubMed Web of Science ®Google Scholar
• Zhong W, Shen H, Zhou F, et al. Osthol inhibits fatty acid synthesis and release via PPARα/γ-mediated pathways in 3T3-L1 adipocytes. Phytochem Lett 2014;8:22–27
   Web of Science ®Google Scholar
• Jarrar MH, Baranova A, Collantes R, et al. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharm Ther 2008;27:412–421
   PubMed Web of Science ®Google Scholar
• Crespo J, Cayon A, Fernandez-Gil P, et al. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 2001;34:1158–1163
   PubMed Web of Science ®Google Scholar
• Fain JN, Madan AK, Hiler ML, et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissue of obese humans. Endocrinology 2004;145:2273–2282
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87–91
   PubMed Web of Science ®Google Scholar
• Ryden M, Arvidsson E, Blomqvist L, et al. Targets for TNF-α-induced lipolysis in human adipocytes. Biochem Bioph Res Co 2004;318:168–175
   PubMed Web of Science ®Google Scholar
• Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003;278:45777–45784
   PubMed Web of Science ®Google Scholar
• Liao PC, Chien SC, Ho CL, et al. Osthole regulates inflammatory mediator expression through modulating NF-κB, mitogen-activated protein kinases, protein kinase C, and reactive oxygen species. J Agric Food Chem 2010;58:10445–10451
   PubMed Web of Science ®Google Scholar
• Chen F, Wang MC, O'Connor JP, et al. Phosphorylation of PPARγ via active ERK1/2 leads to its physical association with p65 and inhibition of NF-κB. J Cell Biochem 2003;90:732–744
   PubMed Web of Science ®Google Scholar
• Kehrer JP, Biswal SS, La E, et al. Inhibition of peroxisome-proliferator-activated receptor (PPAR) alpha by MK886. Biochem J 2001;356:899–906
   PubMedGoogle Scholar
• Leesnitzer LM, Parks DJ, Bledsoe RK, et al. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 2002;41:6640–6650
   PubMed Web of Science ®Google Scholar